External factors
| External factors: |
Methoxyeugenol |
| Category: |
Chemical compounds |
| Phenotype: |
Endometrial cancer |
| Cell name: |
Ishikawa cells |
| Experiment: |
Western blot//Flow cytometry |
| Description: |
According to the median fluorescence intensity(MFI), methoxyeugenol-treated cells did not show an increase in the enzymatic activity of β-galactosidase. As expected, the positive control H2O2 (500 μM) confirmed the SA-β-gal induction. Representative flow cytometric plots are shown. |
Warning: Undefined variable $target_genes in
/data/html/Aging-ReG/public/browse_detail_2.php on line
385
Regulatory relationship
| Regulatory pathway:
|
p53-p21 |
| Official symbol(s): |
Warning: Undefined variable $name_all in /data/html/Aging-ReG/public/browse_detail_2.php on line 525
TP53-CDKN1A
|
| Pathway description: |
p53 expression increase in response to treatments with MET and CPPD. There was no difference in the expression levels of p16 in response to the treatment. MET treatment (60 μM) also raised the expression389 levels of p21 and yet decreased the expression levels of CDK4. and CDK6. |
Aging network
Annotation:
The green line represents Upregulation.
The purple line represents Downregulation.
The orange line represents Activation.
The yellow line represents Inhibition.
The gray line represents Unclear.